Clinical Trials Browser

Phase 3 × Non-Muscle Invasive Bladder Neoplasms × Polysorbates × Clear all

NCT02982395 2019-08-30

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Phase 3 Terminated

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell